Ipca Laboratories Ltd |
In-line; maintain Buy |
BUY
CMP: Rs 298 Target Price: Rs 336
n Despite strong revenue growth operating performance was impacted due to higher staff and other expenses
n Strong revenue growth was driven by 29% growth in domestic formulation business and 27% growth in the exports formulations business
n Addition in the field force has impacted short term profitability but long term growth visibility remains intact
n Maintain earning estimates and Buy rating with a target of Rs336
No comments:
Post a Comment